Home › Companies › BIOATLA INC. › 2023-2024

BIOATLA INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and BIOATLA INC.’s Form 8-K, filed 2024-06-13 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 3Reported items
  • 103Asset managers
  • 402Fund votes
  • 2024-06-13Meeting date

Proxy season: 2023-2024

Explore BIOATLA INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BIOATLA INC.

These tallies are BIOATLA INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-13 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIOATLA INC. — official shareholder meeting results, meeting held 2024-06-13
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Sylvia McBrinn 15,280,856---- 7,634,07511,599,001 Majority: yes

Source: BIOATLA INC., Form 8-K, filed with the SEC on 2024-06-13 — read the filing on EDGAR.

How asset managers voted at the BIOATLA INC. 2023-2024 meeting

Each item below shows how the 103 asset managers that disclosed a BIOATLA INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIOATLA INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTES

Combines 2 wordings of this item as funds reported it.

89% fund support · no official result

FOR 89%11%

The 102 asset managers below cast 89% of the shares they voted on this item FOR (12,480,695 for, 1,549,566 against).

FOR: 12,480,695 (89.0%)AGAINST: 1,549,566 (11.0%)
Largest asset managers voting on “APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at BIOATLA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Soleus Capital Management, L.P.3,894,2920 00For
Vanguard2,104,1120 00For
BlackRock1,655,1920 00For
DWS678,7510 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/0528,358 00Against
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND512,3000 00For
State Street454,581751 00For
MFS0447,519 00Against
Renaissance300,2580 00For
Charles Schwab239,0980 00For
Connor, Clark & Lunn Investment Management Ltd.228,8860 00For
PNC BANK, NATIONAL ASSOCIATION210,8740 00For
ETF Opportunities Trust191,9500 00For
Northern Trust182,107461 00For
MELLON INVESTMENTS Corp177,9890 00For
Nuveen177,8520 00For
TIAA171,8650 00For
UBS137,4860 00For
Two Sigma120,9380 00For
Dimensional0117,643 00Against
BRIDGEWAY CAPITAL MANAGEMENT, LLC090,000 00Against
BRIDGEWAY FUNDS INC090,000 00Against
QUANTITATIVE MASTER SERIES LLC87,4330 00For
CHASE INVESTMENT COUNSEL CORP76,7420 00For
Citadel74,8990 00For

Showing the 25 largest of 102 asset managers. See all 102 in the interactive database.

2. Elect the Class I director listed in the accompanying Proxy Statement, to serve a three-year term expiring at the 2027 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal: Sylvia McBrinn

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

67% Majority: yes · of votes cast

FOR 67%WITHHELD 33%
FOR: 15,280,856WITHHELD: 7,634,075

BIOATLA INC.’s own tally for this item (“Elect Director: Sylvia McBrinn”): 15,280,856 for, 7,634,075 withheld, per its Form 8-K filed 2024-06-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 48,106,317 outstanding shares: 32% for, 16% withheld (47.6% of the company cast a for/withheld vote).

The 36 asset managers below cast 100% of the shares they voted on this item FOR (3,590,657 for, 0 against).

FOR 71%ABSTAIN 29%
FOR: 3,590,657 (70.6%)ABSTAIN: 1,494,827 (29.4%)
Largest asset managers voting on “Elect the Class I director listed in the accompanying Proxy Statement, to serve a three-year term expiring at ” at BIOATLA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,067,8450 00For
BlackRock722,4510 00For
DWS00 676,9150Abstain
MFS00 447,5190Abstain
ETF Opportunities Trust191,9500 00For
TIAA171,8650 00For
Charles Schwab119,5490 00For
BRIDGEWAY FUNDS INC00 90,0000Abstain
QUANTITATIVE MASTER SERIES LLC87,4330 00For
Dimensional00 77,8500Abstain
Equitable59,4920 8,3600For
Pacific Life17,3050 41,7270Abstain
Fidelity39,8280 00For
Prudential/PGIM00 39,1120Abstain
Lincoln Financial37,9000 00For
American Century00 33,7200Abstain
Managed Portfolio Series29,8050 00For
AIG/SunAmerica00 21,7990Abstain
Bridge Builder Trust17,9170 00For
Voya14,8050 00For
John Hancock00 13,3420Abstain
HC CAPITAL TRUST00 11,1910Abstain
Principal Exchange-Traded Funds00 7,7920Abstain
ProShares00 7,1790Abstain
Nationwide1,8230 3,6170Abstain

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

3. Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of BioAtla, Inc. for the fiscal year ending December 31, 2024.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 36 asset managers below cast 100% of the shares they voted on this item FOR (5,085,484 for, 0 against).

FOR: 5,085,484 (100.0%)
Largest asset managers voting on “Ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm of BioAtla, I” at BIOATLA INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,067,8450 00For
BlackRock722,4510 00For
DWS676,9150 00For
MFS447,5190 00For
ETF Opportunities Trust191,9500 00For
TIAA171,8650 00For
Charles Schwab119,5490 00For
BRIDGEWAY FUNDS INC90,0000 00For
QUANTITATIVE MASTER SERIES LLC87,4330 00For
Dimensional77,8500 00For
Equitable67,8520 00For
Pacific Life59,0320 00For
Fidelity39,8280 00For
Prudential/PGIM39,1120 00For
Lincoln Financial37,9000 00For
American Century33,7200 00For
Managed Portfolio Series29,8050 00For
AIG/SunAmerica21,7990 00For
Bridge Builder Trust17,9170 00For
Voya14,8050 00For
John Hancock13,3420 00For
HC CAPITAL TRUST11,1910 00For
Principal Exchange-Traded Funds7,7920 00For
ProShares7,1790 00For
Nationwide5,4400 00For

Showing the 25 largest of 36 asset managers. See all 36 in the interactive database.

Largest BIOATLA INC. shareholders voting in 2023-2024

Ranked by the number of BIOATLA INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 48,106,317 shares outstanding at the time of that meeting.

Top BIOATLA INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1Soleus Capital Management, L.P. 8.10%
2Vanguard 4.37%
3BlackRock 3.44%
4DWS 1.41%
5MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.10%
6HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 1.06%
7State Street 0.95%
8MFS 0.93%
9Renaissance 0.62%
10Charles Schwab 0.50%

Reported BIOATLA INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

BIOATLA INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Acorn Bioventures, L.P. 8.38% DEF14A
Entities affiliated with Soleus Private Equity Fund I, L.P. 8.11% DEF14A
Entities affiliated with Cormorant Asset Management 7.65% DEF14A
Jay M. Short, Ph.D. 7.35% DEF14A
Tang Capital Partners, LP 5.25% DEF14A
Vanguard Group 4.04% 13F
Renaissance Technologies 2.07% 13F
Geode Capital 1.92% 13F
Millennium Management 1.82% 13F
State Street 1.64% 13F

Percentages above are of 48,106,317 shares outstanding, as reported by BIOATLA INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOATLA INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At BIOATLA INC.'s shareholder meeting held 2024-06-13, in the 2023-2024 proxy season, 103 asset managers reported how they voted in their SEC Form N-PX filings, covering 402 separate fund positions. Their filings are grouped here into 3 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. BIOATLA INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — APPROVE, BY A NON-BINDING ADVISORY VOTE, THE EXECUTIVE COMPENSATION OF OUR NAMED EXECUTIVE… — the reporting funds cast 89% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

BIOATLA INC. proxy season coverage: 2023-2024 (this page).